Is Facilitating Pancreatic Beta Cell Regeneration a Valid Option for Clinical Therapy?
Type 1 diabetes (T1D) is an autoimmune disease in which the clinical onset most frequently presents in adolescents who are genetically predisposed. There is accumulating evidence that the endocrine pancreas has regenerative properties, that hematopoietic chimerism can abrogate destruction of beta ce...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2006-01-01
|
| Series: | Cell Transplantation |
| Online Access: | https://doi.org/10.3727/000000006783982322 |